Registry for Chronic Obstructive Pulmonary Disease With Anxiety and Depression in China

• Conditions: Anxiety; COPD; Depression

• Registration Number: NCT03187236
• Lead Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital

Brief Summary

Anxiety and depression are common comorbidities of chronic obstructive pulmonary disease (COPD). However, the exact prevalence is not known in China. COPD patients with anxiety and depression tend to have more severe symptoms and worse prognosis, but the related evidences are not strong enough. The study aim to investigate the prevalence and long-term outcome of anxiety and depression in COPD.

Detailed Description

Not available

Study Timeline

• Status Verified: 2017-06
• Study First Submitted: 2017-06-13
• Study First Submitted QC: 2017-06-13
• Last Update Submitted: 2017-06-13
• Study First Posted: 2017-06-14
• Last Update Posted: 2017-06-14
• Study Start: 2017-06-15
• Primary Completion: 2020-12-31
• Study Completion: 2020-12-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 1906

Inclusion Criteria

• Stable chronic obstructive pulmonary disease (COPD) patients

Exclusion Criteria

• Patients with bronchial asthma or other severe pulmonary diseases or having received pulmonary surgery in 6 months
• Patients with tumor history during past 5 years
• Patients with COPD exacerbations during past 4 weeks
• Participants in clinical trials
• Patients in pregnancy or breastfeeding
• Patients unable to complete questionaire independently
• Patients older than 80 years old
• Patients receiving long-term domiciliary oxygen therapy

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
moderate and severe COPD exacerbations	3 years	total times

Secondary Outcome Measures

Name	Time	Method
All-cause mortality	3 years	mortality in %

Trial Locations

Locations (1)

Peking Union Medical College Hospital; 🇨🇳 Beijing, Beijing, China